Today's Low
₹ 470.60
Today's High
₹ 500.00
52 Weeks Low
₹ 224.95
52 Weeks High
₹ 377.65
Lower
₹ 390.15
Upper
₹ 585.15
Zota Health Care Limited develops, manufactures, and markets pharmaceutical products in India. It offers generic drugs, over-the-counter products, ayurvedic products, and nutraceutical products. The company provides various medicines for chronic illnesses, including heart disease, diabetes, thyroid, and others. As of March 31, 2021, it operated 591 retail stores under the DAVAINDIA name in 24 states of India. The company was founded in 1995 and is headquartered in Surat, India.
No Data Found
No of shares Outstanding
EPS-TTM
Face Value
Book Value
Net Asset Value
ROE
ROA
ROCE
Dividend Yield
Total Debt
Sales Growth
PAT Growth
Particulars | FY 2022 | FY 2021 | FY 2020 | FY 2019 |
---|---|---|---|---|
Total Current Assets | 76.9 | 61.2 | 58.9 | 62.4 |
Total Non-Current Assets | 62.0 | 24.3 | 29.6 | 27.2 |
Total Assets | 138.9 | 85.5 | 88.5 | 89.6 |
Total Current Liabilities | 36.0 | 18.2 | 18.6 | 19.8 |
Total Non-Current Liabilities | 13.4 | 1.0 | 1.1 | 0.9 |
Shareholder's Funds | 89.6 | 66.3 | 68.8 | 68.9 |
Total Liabilities | 138.9 | 85.5 | 88.5 | 89.6 |
The Industry Quick Ratio stands at 1.60, vs the Quick Ratio of 1.80, which results in a Positive aspect.
The Industry Debt to Equity Ratio stands at 0.22, vs the Debt to Equity Ratio of 0.00, which results in a Positive aspect.
The Industry Current Ratio stands at 2.30, vs the Current Ratio of 3.17, which results in a Positive aspect.
The Industry Price to BV stands at 6.18, vs the Price to BV of 13.08, which results in a Positive aspect.
Particulars | FY 2022 | FY 2021 | FY 2020 | FY 2019 |
---|---|---|---|---|
Total Income | 131.2 | 106.8 | 95.1 | 85.6 |
Total Expenditure | 116.7 | 106.2 | 90.6 | 77.9 |
Operating Profit(Excl OI) | 16.4 | 1.9 | 6.0 | 9.3 |
Add: Other Income | 2.0 | 1.3 | 1.5 | 1.5 |
Operating Profit | 16.4 | 1.9 | 6.0 | 9.3 |
Less: Interest | 0.3 | 0.1 | 0.1 | 0.0 |
PBDT | 16.1 | 1.8 | 6.0 | 9.3 |
Less: Depreciation Amortization | 3.7 | 3.2 | 2.1 | 1.4 |
PBT & Exceptional Items | 12.4 | -1.4 | 3.9 | 7.9 |
Less: Exceptional Income Expenses | 0.0 | 1.0 | 0.0 | 0.0 |
Profit Before Tax | 12.4 | -0.4 | 3.9 | 7.9 |
Less: Taxation | 3.5 | -0.2 | 1.1 | 2.3 |
Profit After Tax | 8.9 | -0.2 | 2.7 | 5.6 |
Earnings Per Share | 0.0 | 0.0 | 0.0 | 0.0 |
The Industry PE Ratio stands at 42.46, vs the PE Ratio of 0.00, which results in a Negative aspect.
The Industry PAT Growth stands at 32.38, vs the PAT Growth of -50.59, which results in a Negative aspect.
The Industry Dividend Yield stands at 0.59, vs the Dividend Yield of 0.21, which results in a Negative aspect.
The Industry PAT Margin stands at 9.70, vs the PAT Margin of 2.88, which results in a Negative aspect.
Particulars | FY 2023 | FY 2022 | FY 2021 | FY 2020 | FY 2019 |
---|---|---|---|---|---|
Profit Before Tax | -4.7 | 12.4 | -0.4 | 3.9 | 7.9 |
Tax Paid | -2.1 | -3.7 | -0.1 | -1.1 | -2.3 |
Adjustment | 13.1 | 2.7 | 1.4 | 1.1 | 0.0 |
Changes In Working Capital | -4.7 | 12.4 | -0.4 | 3.9 | 7.9 |
Cash Flow after changes in Working Capital | 0.1 | 17.1 | -0.8 | 6.7 | -0.9 |
Cash Flow from Operating Activities | -2.0 | 13.3 | -0.9 | 5.6 | -3.2 |
Cash Flow from Investing Activities | 14.7 | -26.7 | 3.8 | -3.5 | 8.8 |
Cash Flow from Financing Activities | -13.9 | 14.3 | -2.4 | -2.9 | -6.3 |
Net Cash Inflow / Outflow | -1.2 | 1.0 | 0.5 | -0.9 | -0.8 |
Opening Cash & Cash Equivalents | 2.3 | 1.3 | 0.8 | 1.7 | 2.5 |
Closing Cash & Cash Equivalent | 1.1 | 2.3 | 1.3 | 0.8 | 1.7 |
The Industry PCF RATIO stands at 24.34, vs the PCF RATIO of 57.56, which results in a Positive aspect.
The Industry PFCF Ratio stands at 25.23, vs the PFCF Ratio of 814.61, which results in a Positive aspect.
Particulars | Dec 2023 | Sep 2023 | Jun 2023 | Mar 2023 | Dec 2022 | Sep 2022 | Jun 2022 | Mar 2022 | Dec 2021 | Sep 2021 | Jun 2021 | Mar 2021 | Dec 2020 | Sep 2020 | Jun 2020 | Mar 2020 |
---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|
Net Sales | 469.3 | 452.7 | 386.5 | 368.5 | 349.7 | 389.5 | 291.9 | 313.4 | 310.3 | 353.9 | 334.4 | 305.9 | 304.8 | 281.7 | 175.5 | 230.8 |
Total Income | 470.8 | 456.7 | 388.0 | 368.7 | 355.8 | 397.9 | 296.7 | 321.5 | 313.6 | 355.7 | 337.5 | 308.4 | 310.5 | 283.8 | 177.8 | 236.1 |
Total Expenditure | 436.0 | 408.5 | 373.7 | 358.2 | 349.4 | 341.2 | 277.5 | 312.8 | 260.3 | 305.3 | 285.6 | 307.8 | 316.7 | 273.1 | 164.0 | 215.7 |
PBIDT (Excl OI) | 33.3 | 44.3 | 12.8 | 10.3 | 0.3 | 48.4 | 14.4 | 0.6 | 50.0 | 48.6 | 48.9 | -1.9 | -11.9 | 8.5 | 11.5 | 15.1 |
Other Income | 1.5 | 4.0 | 1.5 | 0.3 | 6.2 | 8.4 | 4.7 | 8.1 | 3.4 | 1.8 | 3.0 | 2.5 | 5.7 | 2.1 | 2.3 | 5.3 |
Operating Profit | 34.9 | 48.2 | 14.3 | 10.6 | 6.4 | 56.8 | 19.2 | 8.7 | 53.3 | 50.4 | 51.9 | 0.5 | -6.2 | 10.6 | 13.8 | 20.4 |
Interest | 11.4 | 11.4 | 8.3 | 8.1 | 7.1 | 6.6 | 3.8 | 2.9 | 0.2 | 0.1 | 0.1 | 0.5 | 0.3 | 0.2 | 0.1 | 0.2 |
Exceptional Items | 0.0 | 0.0 | 0.0 | 5.4 | 0.0 | 0.0 | 0.0 | 0.0 | 0.0 | 0.0 | 0.0 | 0.0 | 0.0 | 10.3 | 0.0 | 0.0 |
PBDT | 23.5 | 36.9 | 6.0 | 7.8 | -0.7 | 50.1 | 15.4 | 5.9 | 53.2 | 50.2 | 51.8 | 0.0 | -6.5 | 20.8 | 13.8 | 20.2 |
Depreciation | 50.8 | 48.0 | 34.1 | 38.8 | 33.0 | 28.7 | 19.1 | 15.8 | 7.8 | 6.8 | 6.3 | 8.6 | 8.0 | 7.7 | 7.4 | 10.0 |
Profit Before Tax | -27.3 | -11.1 | -28.1 | -30.9 | -33.7 | 21.5 | -3.8 | -10.0 | 45.3 | 43.4 | 45.6 | -8.6 | -14.5 | 13.1 | 6.4 | 10.2 |
Tax | 2.1 | 5.4 | 0.3 | -4.6 | -1.4 | 12.4 | 4.4 | 0.2 | 11.9 | 11.3 | 11.9 | -1.3 | -4.4 | 2.9 | 1.3 | 3.1 |
Provisions and contingencies | 0.0 | 0.0 | 0.0 | 0.0 | 0.0 | 0.0 | 0.0 | 0.0 | 0.0 | 0.0 | 0.0 | 0.0 | 0.0 | 0.0 | 0.0 | 0.0 |
Profit After Tax | -29.4 | -16.5 | -28.4 | -26.4 | -32.3 | 9.1 | -8.2 | -10.1 | 33.4 | 32.1 | 33.7 | -7.3 | -10.1 | 10.2 | 5.1 | 7.1 |
Net Profit | -29.4 | -16.5 | -28.4 | -26.4 | -32.3 | 9.1 | -8.2 | -10.1 | 33.4 | 32.1 | 33.7 | -7.3 | -10.1 | 10.2 | 5.1 | 7.1 |
ADDITIONAL INFOS: | ||||||||||||||||
Equity Capital | 258.5 | 258.5 | 251.6 | 251.6 | 251.6 | 251.6 | 251.6 | 251.6 | 251.6 | 251.6 | 245.6 | 245.6 | 245.6 | 245.6 | 245.6 | 245.6 |
Reserves | 0.0 | 0.0 | 0.0 | 0.0 | 0.0 | 0.0 | 0.0 | 0.0 | 0.0 | 0.0 | 0.0 | 0.0 | 0.0 | 0.0 | 0.0 | 0.0 |
EPS | -1.1 | -0.6 | -1.1 | -1.1 | -1.3 | 0.4 | -0.3 | -0.4 | 1.3 | 1.3 | 1.4 | -0.3 | -0.4 | 0.4 | 0.2 | 0.3 |
Operating Profit Margin | 7.4 | 10.7 | 3.7 | 2.9 | 1.8 | 14.6 | 6.6 | 2.8 | 17.2 | 14.2 | 15.5 | 0.2 | -2.0 | 3.8 | 7.9 | 8.8 |
Net Profit Margin | -6.3 | -3.7 | -7.3 | -7.2 | -9.2 | 2.3 | -2.8 | -3.2 | 10.8 | 9.1 | 10.1 | -2.4 | -3.3 | 3.6 | 2.9 | 3.1 |
The Industry Mcap Growth stands at 19.42, vs the Mcap Growth of -29.79, which results in a Negative aspect.
The Industry Net Sales Growth stands at 11.00, vs the Net Sales Growth of 11.07, which results in a Positive aspect.
Type | Classic | Woodie | Camarilla |
---|---|---|---|
R4 | 533.30 | 568.10 | 490.67 |
R3 | 522.20 | 518.60 | 482.59 |
R2 | 511.10 | 509.30 | 479.89 |
R1 | 492.80 | 489.20 | 477.20 |
Pivot | 481.70 | 479.90 | 481.70 |
S1 | 463.40 | 459.80 | 471.81 |
S2 | 452.30 | 450.50 | 469.11 |
S3 | 434.00 | 430.40 | 466.42 |
S4 | 415.70 | 391.70 | 458.33 |
(All Values are in INR)
1 Day
1 Week
1 Month
Stoch RSI
36.56
Neutral
RSI
43.09
Neutral
ROC
-9.13
Bearish
UltimateOscillator
28.59
Bearish
Williams Indicator
-74.99
Neutral
CCI Indicator
-68.68
Neutral
MACD
-2,592.28
Bearish
Stochastic Indicator
29.09
Neutral
ATR
21.85
Low Volatility
Ex-Date | Ratio | Record Date |
---|
Ex-Date | Ratio | Record Date |
---|---|---|
Announcement Date | Dividend Amount | Dividend Percentage of FV | Dividend Type |
---|---|---|---|
22-09-2023 | 1.00 | 10 | Final |
19-09-2022 | 1.50 | 15 | Final |
22-09-2021 | 1.00 | 10 | Final |
Date Of Conduct | Board Meeting Details |
---|---|
08-02-2024 | Financial Results/Other business matters |
10-11-2023 | Financial Results/Other business matters |
14-08-2023 | ZOTA HEALTH CARE LIMITED has informed the Exchange about Board Meeting to be held on 14-Aug-2023 to consider and approve the Quarterly Unaudited Financial results of the Company for the period ended June 2023 and Other business. |
15-06-2023 | Fund Raising/Other business matters |
30-05-2023 | Financial Results/Dividend/Other business matters |
13-02-2023 | Financial Results/Other business matters |
11-01-2023 | Other business matters |
14-11-2022 | Financial results/Other business matters |
02-09-2022 | Other business matters |
13-08-2022 | Financial results/Other business matters |
30-05-2022 | Dividend/Financial results/Other business matters |
12-02-2022 | Financial Results/Other business matters |
01-11-2021 | Financial Results/Other business matters |
02-09-2021 | Other business matters |
11-08-2021 | Fund Raising/Other business matters |
30-07-2021 | Financial Results/Other business matters |
25-06-2021 | Financial Results/Dividend/Other business matters |